Effect of Sarpogrelate, a Serotonin Receptor Antagonist, on Progression of Coronary Artery Disease

Trial Profile

Effect of Sarpogrelate, a Serotonin Receptor Antagonist, on Progression of Coronary Artery Disease

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 May 2016

At a glance

  • Drugs Sarpogrelate (Primary) ; Aspirin
  • Indications Coronary artery disease
  • Focus Therapeutic Use
  • Acronyms SAGE-CAD
  • Most Recent Events

    • 02 May 2016 Status changed from recruiting to completed.
    • 20 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top